15 September 2022

PHARMANUTRA S.P.A. LAUNCHES NEW PRODUCTS CETILAR® ORO AND APPORTAL® VITAL

14 September 2022

HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2022

05 September 2022

THE BOD APPROVES THE FIRST HALF FINANCIAL REPORT AS AT 30/06/2022 AND THE GROUP’S FIRST SUSTAINABILITY REPORT

04 August 2022

BUY-BACK REPORT JULY 2022

26 July 2022

PHARMANUTRA S.P.A.: FIRST ACQUISITION CLOSING OF AKERN S.R.L. FINALISED

06 July 2022

BUY-BACK REPORT JUNE 2022

17 June 2022

GOLDEN POWER NOTIFICATION FILED IN CONNECTION WITH THE ACQUISITION OF 100% OF AKERN S.R.L.

15 June 2022

SIGNING OF THE AGREEMENT FOR THE ACQUISITION OF 100% OF AKERN S.R.L.

08 June 2022

BUY-BACK REPORT MAY 2022

27 May 2022

PUBLICATION OF THE SHAREHOLDERS’ MEETINGS MINUTES HELD ON 27/04/2022

16 May 2022

PHARMANUTRA S.P.A.: INITIATION OF SHARE BUY-BACK PROGRAM

12 May 2022

INTERIM FINANCIAL REPORT AS OF 31 MARCH 2022 NOW AVAILABLE

1 2 … 15